Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Psychopharmacology for the Clinician"'
Publikováno v:
Journal of Psychiatry & Neuroscience : JPN
A 29-year-old man with schizophrenia treated with aripiprazole 15 mg/d visited his psychiatrist accompanied by his mother, who mentioned that although her son is doing well, she must remind him to take his medication. The psychiatrist offered the pat
Autor:
Sagué-Vilavella, Maria, López-Pelayo, Hugo, Arbelo, Néstor, Cámara, Mercè, Gomes, Susana, Madero, Santiago, Pons-Cabrera, Maria Teresa, Pintor, Luis
Publikováno v:
J Psychiatry Neurosci
Schizophrenia Research
Schizophrenia Research
Using Richardson and Davidson's model and the sciences of pharmacokinetics and clinical pharmacopsychology, this article reviewed the: (1) poor life expectancy associated with treatment-resistant schizophrenia (TRS), which may be improved in patients
Publikováno v:
Journal of Psychiatry and Neuroscience, 46(3), E388-E389. Canadian Medical Association
Journal of Psychiatry & Neuroscience : JPN
Muntingh, A, Batelaan, N, Scholten, W & van Balkom, A J 2021, ' To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians ', Journal of Psychiatry and Neuroscience, vol. 46, no. 3, pp. E388-E389 . https://doi.org/10.1503/jpn.200099
Journal of Psychiatry & Neuroscience : JPN
Muntingh, A, Batelaan, N, Scholten, W & van Balkom, A J 2021, ' To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians ', Journal of Psychiatry and Neuroscience, vol. 46, no. 3, pp. E388-E389 . https://doi.org/10.1503/jpn.200099
A 35-year-old woman presented seeking advice on whether to discontinue antidepressants. Several years previously she had suffered from a panic disorder that was effectively treated with cognitive behavioural therapy (CBT). A few years following remis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a600a32b58eaa384f107d2be7e220a
https://research.vumc.nl/en/publications/1a12f0d6-841a-4700-8834-e4182a60e349
https://research.vumc.nl/en/publications/1a12f0d6-841a-4700-8834-e4182a60e349
Publikováno v:
Journal of Psychiatry & Neuroscience : JPN
A 22-year-old man is starting out-patient follow-up for a first episode of psychosis (FEP) that started in the context of a severe cannabis use disorder. The patient initially required 3 months of hospitalization and was stabilized with paliperidone.
Autor:
Jacob Cookey
Publikováno v:
Journal of Psychiatry & Neuroscience : JPN
A man in his 60s with longstanding major depressive disorder was stabilized for more than 30 years on phenelzine, which is a nonselective monoamine oxidase inhibitor (MAOI). Unfortunately, his medication had to be discontinued because of a global sho
Publikováno v:
Journal of Psychiatry & Neuroscience : JPN
A 27-year-old man was admitted to our psychiatry service with psychotic symptoms. In the months preceding admission, he had experienced ideas of reference along with persecutory delusion. He also exhibited associated behavioural and affective impairm
Publikováno v:
J Psychiatry Neurosci
Brain and Mind Institute Researchers' Publications
Brain and Mind Institute Researchers' Publications
Publikováno v:
J Psychiatry Neurosci
Journal of Psychiatry and Neuroscience
Journal of Psychiatry and Neuroscience, Canadian Medical Association, 2020, 45 (2), pp.143-144. ⟨10.1503/jpn.190182⟩
Journal of Psychiatry and Neuroscience
Journal of Psychiatry and Neuroscience, Canadian Medical Association, 2020, 45 (2), pp.143-144. ⟨10.1503/jpn.190182⟩
A 55-year-old man presented to our outpatient department for severe cannabis use disorder (CUD): he had been using 10 joints of cannabis resin per day for 25 years. He reported a withdrawal syndrome with dysphoria, anxiety and insomnia. He was highly
Publikováno v:
Journal of Psychiatry & Neuroscience : JPN
A 30-year-old man with a 2-year history of treatment-resistant depression presented for his monthly outpatient psychiatric follow-up. His latest medication trial consisted of escitalopram 20 mg and mirtazapine 30 mg daily for 4 weeks. The patient was
Publikováno v:
Journal of Psychiatry & Neuroscience : JPN
A 23-year-old university student was initially seen for symptoms of long-standing social anxiety disorder (SAD). Her primary symptoms included excessive shyness and avoidance of peer-related activities, large family gatherings, speaking with authorit